Yes its been used as the brand name "Elmiron" in a pill format. Bio-Availability for such conditions as OA is low in Pill format.
Thus needs injections. But for new applications (such as OA, MPS, RRV etc) they need clinical trials to prove they are safe, effective etc.
PAR -v- CUV, page-12
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.005(2.50%) |
Mkt cap ! $75.30M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $135.1K | 637.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 42306 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 73756 | 8 |
View Market Depth
| Last trade - 15.03pm 03/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |